These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 7755562)
1. Inhibition of bone resorption in vitro by selective inhibitors of gelatinase and collagenase. Hill PA; Docherty AJ; Bottomley KM; O'Connell JP; Morphy JR; Reynolds JJ; Meikle MC Biochem J; 1995 May; 308 ( Pt 1)(Pt 1):167-75. PubMed ID: 7755562 [TBL] [Abstract][Full Text] [Related]
2. The effects of selective inhibitors of matrix metalloproteinases (MMPs) on bone resorption and the identification of MMPs and TIMP-1 in isolated osteoclasts. Hill PA; Murphy G; Docherty AJ; Hembry RM; Millican TA; Reynolds JJ; Meikle MC J Cell Sci; 1994 Nov; 107 ( Pt 11)():3055-64. PubMed ID: 7699005 [TBL] [Abstract][Full Text] [Related]
3. The cellular actions of interleukin-11 on bone resorption in vitro. Hill PA; Tumber A; Papaioannou S; Meikle MC Endocrinology; 1998 Apr; 139(4):1564-72. PubMed ID: 9528935 [TBL] [Abstract][Full Text] [Related]
4. Functional heterogeneity of osteoclasts: matrix metalloproteinases participate in osteoclastic resorption of calvarial bone but not in resorption of long bone. Everts V; Korper W; Jansen DC; Steinfort J; Lammerse I; Heera S; Docherty AJ; Beertsen W FASEB J; 1999 Jul; 13(10):1219-30. PubMed ID: 10385612 [TBL] [Abstract][Full Text] [Related]
5. Regulation of matrix metalloproteinases (MMP-2, -3, -9, and -13) by interleukin-1 and interleukin-6 in mouse calvaria: association of MMP induction with bone resorption. Kusano K; Miyaura C; Inada M; Tamura T; Ito A; Nagase H; Kamoi K; Suda T Endocrinology; 1998 Mar; 139(3):1338-45. PubMed ID: 9492070 [TBL] [Abstract][Full Text] [Related]
6. Interleukin-1 and tumor necrosis factor-alpha induce collagenolysis and bone resorption by regulation of matrix metalloproteinase-2 in mouse calvarial bone cells. Kang BS; Park YG; Cho JY; Kim JK; Lee TK; Kim DW; Gu YH; Suzuki I; Chang YC; Kim CH Immunopharmacol Immunotoxicol; 2003 Aug; 25(3):347-64. PubMed ID: 19180798 [TBL] [Abstract][Full Text] [Related]
7. Cysteine proteinases and matrix metalloproteinases play distinct roles in the subosteoclastic resorption zone. Everts V; Delaissé JM; Korper W; Beertsen W J Bone Miner Res; 1998 Sep; 13(9):1420-30. PubMed ID: 9738514 [TBL] [Abstract][Full Text] [Related]
8. EGF and IL-1 alpha modulate the release of collagenase, gelatinase and TIMP-1 as well as the release of calcium by rabbit calvarial bone explants. van der Zee E; Jansen I; Hoeben K; Beertsen W; Everts V J Periodontal Res; 1998 Jan; 33(1):65-72. PubMed ID: 9524323 [TBL] [Abstract][Full Text] [Related]
9. The effects of serine proteinase inhibitors on bone resorption in vitro. Tumber A; Papaioannou S; Breckon J; Meikle MC; Reynolds JJ; Hill PA J Endocrinol; 2003 Sep; 178(3):437-47. PubMed ID: 12967336 [TBL] [Abstract][Full Text] [Related]
10. Cystatin C, and inhibitor of bone resorption produced by osteoblasts. Lerner UH; Johansson L; Ranjsö M; Rosenquist JB; Reinholt FP; Grubb A Acta Physiol Scand; 1997 Sep; 161(1):81-92. PubMed ID: 9381954 [TBL] [Abstract][Full Text] [Related]
11. Osteoblasts mediate insulin-like growth factor-I and -II stimulation of osteoclast formation and function. Hill PA; Reynolds JJ; Meikle MC Endocrinology; 1995 Jan; 136(1):124-31. PubMed ID: 7828521 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of bone resorption by selective inactivators of cysteine proteinases. Hill PA; Buttle DJ; Jones SJ; Boyde A; Murata M; Reynolds JJ; Meikle MC J Cell Biochem; 1994 Sep; 56(1):118-30. PubMed ID: 7806585 [TBL] [Abstract][Full Text] [Related]
15. Osteoclastic bone degradation and the role of different cysteine proteinases and matrix metalloproteinases: differences between calvaria and long bone. Everts V; Korper W; Hoeben KA; Jansen ID; Bromme D; Cleutjens KB; Heeneman S; Peters C; Reinheckel T; Saftig P; Beertsen W J Bone Miner Res; 2006 Sep; 21(9):1399-408. PubMed ID: 16939398 [TBL] [Abstract][Full Text] [Related]
16. Bone-derived growth factors modulate collagenase and TIMP (tissue inhibitor of metalloproteinases) activity and type I collagen degradation by mouse calvarial osteoblasts. Meikle MC; McGarrity AM; Thomson BM; Reynolds JJ Bone Miner; 1991 Jan; 12(1):41-55. PubMed ID: 1848130 [TBL] [Abstract][Full Text] [Related]
17. Type I collagen degradation by mouse calvarial osteoblasts stimulated with 1,25-dihydroxyvitamin D-3: evidence for a plasminogen-plasmin-metalloproteinase activation cascade. Thomson BM; Atkinson SJ; McGarrity AM; Hembry RM; Reynolds JJ; Meikle MC Biochim Biophys Acta; 1989 Nov; 1014(2):125-32. PubMed ID: 2554972 [TBL] [Abstract][Full Text] [Related]
18. Human osteoblasts in culture synthesize collagenase and other matrix metalloproteinases in response to osteotropic hormones and cytokines. Meikle MC; Bord S; Hembry RM; Compston J; Croucher PI; Reynolds JJ J Cell Sci; 1992 Dec; 103 ( Pt 4)():1093-9. PubMed ID: 1336777 [TBL] [Abstract][Full Text] [Related]
19. Bone-resorbing agents affect the production and distribution of procollagenase as well as the activity of collagenase in bone tissue. Delaisse JM; Eeckhout Y; Vaes G Endocrinology; 1988 Jul; 123(1):264-76. PubMed ID: 2838255 [TBL] [Abstract][Full Text] [Related]
20. Prostaglandin-independent stimulation of bone resorption in mouse calvariae and in isolated rat osteoclasts by thyroid hormones (T4, and T3). Conaway HH; Ransjö M; Lerner UH Proc Soc Exp Biol Med; 1998 Feb; 217(2):153-61. PubMed ID: 9452138 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]